Argent Trust CO Abbott Laboratories Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Argent Trust CO holds 147,147 shares of ABT stock, worth $16.9 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

147,147

Previous 149,742 1.73%

Holding current value

$16.9 Million

Previous $15.6 Million 7.82%

% of portfolio

0.7%

Previous 0.69%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $259,681 - $306,547	-2,595 Reduced 1.73%	147,147 $16.8 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $1,007 - $1,124	-10 Reduced 0.01%	149,742 $15.6 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $789,420 - $871,879	7,208 Added 5.06%	149,752 $17 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $307,547 - $376,464	3,410 Added 2.45%	142,544 $15.7 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $184,659 - $221,560	1,933 Added 1.41%	139,134 $13.5 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $359,079 - $400,089	3,563 Added 2.67%	137,201 $15 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $20,243 - $23,828	209 Added 0.16%	133,638 $13.5 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $100,003 - $117,319	1,052 Added 0.79%	133,429 $14.7 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $101,017 - $116,959	-1,044 Reduced 0.78%	132,377 $12.8 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $1,428 - $1,727	-14 Reduced 0.01%	133,421 $14.5 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $213,331 - $260,143	-1,871 Reduced 1.38%	133,435 $15.8 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $297,605 - $364,400	-2,576 Reduced 1.87%	135,306 $19 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $17,149 - $18,971	-147 Reduced 0.11%	137,882 $16.3 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $118,907 - $139,971	-1,124 Reduced 0.81%	138,029 $16 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $696,140 - $820,159	6,396 Added 4.82%	139,153 $16.7 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $196,560 - $214,194	1,872 Added 1.43%	132,757 $14.5 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $377,923 - $458,959	4,124 Added 3.25%	130,885 $14.2 Million
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $373,508 - $478,044	4,878 Added 4.0%	126,761 $11.6 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $188,083 - $275,028	-2,994 Reduced 2.4%	121,883 $9.62 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $152,937 - $170,255	1,948 Added 1.58%	124,877 $10.8 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $885,999 - $960,699	10,826 Added 9.66%	122,929 $10.3 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $211,206 - $246,330	2,898 Added 2.65%	112,103 $9.43 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $34,301 - $41,471	518 Added 0.48%	109,205 $8.73 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $109,222 - $123,733	-1,666 Reduced 1.51%	108,687 $7.86 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $4,864 - $5,868	80 Added 0.07%	110,353 $8.05 Million
Q2 2018 Apr 15, 2019	BUY	$57.57 - $63.54 $120,263 - $132,735	2,089 Added 1.93%	110,273 $6.72 Million
Q2 2018 Aug 15, 2018	BUY	$57.57 - $63.54 $2.8 Million - $3.09 Million	48,624 Added 81.64%	108,184 $6.6 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $2.36 Million - $2.67 Million	41,970 Added 238.6%	59,560 $3.57 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $464,063 - $496,828	-8,645 Reduced 32.95%	17,590 $1 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.26 Million - $1.41 Million	26,235	26,235 $1.4 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account